The US is rapidly accelerating research into psychedelics for mental illness, signaling a major shift from counterculture to mainstream R&D. That change should push India to revisit its drug policies and build the ecosystem needed for responsible progress. With deep cultural ties to altered states, India can lead by funding research centers, developing therapies, and modernizing legal frameworks.
The US Department of Justice is easing federal rules on certain marijuana items by reclassifying the drug as less dangerous. The shift could reduce research hurdles and lessen tax burdens, while aligning federal policy more closely with scientific and medical understanding. Supporters say it may also improve access for patients nationwide, with major implications for the $47 billion cannabis industry.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
